Envista Holdings Corporation

Healthcare · EUR · F

0HV

Price

€20.093

+4.04%

Cap

€3.94B

Earnings

—

30d Trend

-12.0%

0HV

Loading chart data...

0 days · % change from startPowered by Brain47

VolatilityHigh

47% annualised over 90 days

BRAIN47 SIGNAL

STRONG

Risk Level63

Quality64

Momentum80

Technical50

Fundamentals60

Raw weighted: 61×Macro 0.99 (−1%)=60

RISK

63/100

90d Volatility

46.8%High

ATR %

3.8%High daily moves

Max Drawdown (1Y)

-23.8%Normal

QUALITY

64/100

ROE (avg)

1.5%Weak

Piotroski F-Score

9/9Strong

Debt/Equity

0.47Low leverage

Margin Stability

CV 2.8%Very stable

Accruals

-4.0%Cash earnings

Interest Coverage

3.4xAdequate

MOMENTUM

80/100

12-1M Momentum

+36.8%Strong uptrend

6-1M Momentum

+21.9%Positive

1M Return

-8.6%Recent pullback

Relative Strength

-0.1% vs sectorIn-line

TECHNICAL

50/100

RSI (14)

40.3Neutral

Price vs SMA200

+1.9%Flat

MACD

0.00Bearish momentum

Bollinger Band

36%Mid-range

SMA Cross

Death CrossDeath Cross

Trend Quality (KER)

0.276Noisy/choppy

FUNDAMENTALS

60/100

EV/EBIT

22.2Fair

P/FCF

19.8Fair

P/S

1.7Cheap

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months41

3-12 months ★61

1-5+ years61

6-9 month opportunity — emerging trend

BRAIN47'S ASSESSMENT

I rate Envista Holdings Corporation at 60/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 80/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

-8.6%

3 MONTHS

-19.0%

12 MONTHS

+28.2%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month opportunity — emerging trend. Momentum (80) and Quality (64) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 47%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 60/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.